BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 36916370)

  • 1. [Risk factors of early death after lung transplantation in patients with idiopathic pulmonary fibrosis complicated with pulmonary arterial hypertension].
    Hu C; Liu M; Yu H; Wang J; Li X; Yue B; Huang D; Hu C; Chen J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Feb; 35(2):124-129. PubMed ID: 36916370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Outcomes of idiopathic pulmonary fibrosis patients with high body mass index undergoing extracorporeal membrane oxygenation support].
    Tian J; Dong Y; Zhou T; Zhang J; Xu H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 May; 36(5):538-542. PubMed ID: 38845503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic performance of pulmonary effective arterial elastance in patients with heart failure].
    Wu YH; Huang BP; Feng JY; Huang LY; Zhao XM; Wang J; Guan JY; Li XQ; Zhang YH; Zhang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Apr; 52(4):397-404. PubMed ID: 38644255
    [No Abstract]   [Full Text] [Related]  

  • 4. Asymmetric Dimethylarginine and NT-proBNP Levels Provide Synergistic Information in Pulmonary Arterial Hypertension.
    Shafran I; Probst V; Panzenböck A; Sadushi-Kolici R; Gerges C; Wolzt M; Segel MJ; Celermajer DS; Lang IM; Skoro-Sajer N
    JACC Heart Fail; 2024 Jun; 12(6):1089-1097. PubMed ID: 38573264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index is associated with clinical outcomes in idiopathic pulmonary fibrosis.
    Yoon HY; Kim H; Bae Y; Song JW
    Sci Rep; 2024 May; 14(1):11921. PubMed ID: 38789476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of Left-to-Right Shunt Repair in Children with Pulmonary Arterial Hypertension at a Tertiary Hospital in a Low-to-Middle-Income Country.
    Arafuri N; Murni IK; Idris NS; Uiterwaal CSPM; Savitri AI; Nugroho S; Noormanto N
    Glob Heart; 2021 Apr; 16(1):25. PubMed ID: 34040938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study.
    Yoon HY; Kim H; Bae Y; Song JW
    Respir Res; 2024 Apr; 25(1):191. PubMed ID: 38685071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental prognostic value of arterial elastance in mild-to-moderate idiopathic pulmonary fibrosis.
    Sonaglioni A; Caminati A; Nicolosi GL; Lombardo M; Harari S
    Int J Cardiovasc Imaging; 2022 Jul; 38(7):1473-1485. PubMed ID: 35103898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung transplantation for hypersensitivity pneumonitis.
    Kern RM; Singer JP; Koth L; Mooney J; Golden J; Hays S; Greenland J; Wolters P; Ghio E; Jones KD; Leard L; Kukreja J; Blanc PD
    Chest; 2015 Jun; 147(6):1558-1565. PubMed ID: 25412059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of Serum Galectin-3 Binding Protein Level in Patients with Pulmonary Arterial Hypertension.
    Li M; Pan W; Tian D; Chen D; Zhang X; Zhang Y; Chen S; Zhou D; Ge J
    Curr Vasc Pharmacol; 2024; 22(1):67-77. PubMed ID: 38038005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal hypercapnia with daytime normocapnia in patients with advanced pulmonary arterial hypertension awaiting lung transplantation.
    Nakatsuka Y; Chen-Yoshikawa T; Kinoshita H; Aoyama A; Kubo H; Murase K; Hamada S; Takeyama H; Minami T; Takahashi N; Tanizawa K; Handa T; Hirai T; Date H; Chin K
    PLoS One; 2020; 15(4):e0227775. PubMed ID: 32294102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung transplantation in primary pulmonary arterial hypertension and pulmonary venous hypertension.
    Sainathan S; Ryan J; Mullinari L; Sanchez P
    Clin Transplant; 2024 Jan; 38(1):e15158. PubMed ID: 37788166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Step towards understanding coronary artery disease: a complication in idiopathic pulmonary fibrosis.
    Sinha R; Nanavaty D; Azhar A; Devarakonda P; Singh S; Garikipati R; Sanghvi A; Manoharan S; Parhar G; Zaman K; Ayala-Rodriguez C; Vasudevan V; Reddy S; Gerolemou L
    BMJ Open Respir Res; 2024 Mar; 11(1):. PubMed ID: 38508700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the "sex paradox" in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR).
    DesJardin JT; Kime N; Kolaitis NA; Kronmal RA; Lammi MR; Mathai SC; Ventetuolo CE; De Marco T;
    J Heart Lung Transplant; 2024 Jun; 43(6):901-910. PubMed ID: 38360160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Transplant Outcomes for Idiopathic Pulmonary Fibrosis: Are We Improving?
    Anderson S; Reck Dos Santos P; Langlais B; Campany M; Donato B; D'Cunha J
    Ann Thorac Surg; 2024 Apr; 117(4):820-827. PubMed ID: 37625610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
    Oldham JM; Huang Y; Bose S; Ma SF; Kim JS; Schwab A; Ting C; Mou K; Lee CT; Adegunsoye A; Ghodrati S; Pugashetti JV; Nazemi N; Strek ME; Linderholm AL; Chen CH; Murray S; Zemans RL; Flaherty KR; Martinez FJ; Noth I
    Am J Respir Crit Care Med; 2024 May; 209(9):1111-1120. PubMed ID: 37847691
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of the impact of social deprivation, distance to hospital and time to diagnosis on survival in idiopathic pulmonary fibrosis.
    Shankar R; Hadinnapola CM; Clark AB; Adamali H; Chaudhuri N; Spencer LG; Wilson AM
    Respir Med; 2024 Jun; 227():107612. PubMed ID: 38677526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression.
    Ruan P; Todd JL; Zhao H; Liu Y; Vinisko R; Soellner JF; Schmid R; Kaner RJ; Luckhardt TR; Neely ML; Noth I; Porteous M; Raj R; Safdar Z; Strek ME; Hesslinger C; Palmer SM; Leonard TB; Salisbury ML
    Respir Res; 2023 May; 24(1):141. PubMed ID: 37344825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease.
    O'Dwyer DN; Kim JS; Ma SF; Ranjan P; Das P; Lipinski JH; Metcalf JD; Falkowski NR; Yow E; Anstrom K; Dickson RP; Huang Y; Gilbert JA; Martinez FJ; Noth I
    Am J Respir Crit Care Med; 2024 May; 209(9):1101-1110. PubMed ID: 38051927
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype.
    Steger M; Canuet M; Enache I; Goetsch T; Labani A; Meyer L; Martin G; Kessler R; Montani D; Riou M
    Respir Med; 2024; 225():107585. PubMed ID: 38479707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.